2021 annual financial data
BriaCell Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -7,112,521 USD and net income was -13,816,200 USD.
Operating cash flow was -7,750,188 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,112,521 USD
- Net income
- -13,816,200 USD
- Operating cash flow
- -7,750,188 USD